| Name | Title | Contact Details |
|---|
Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company`s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.
We are a collection of individuals focused on discovering and developing drugs for patients with grievous genetic diseases.
Lybradyn Inc is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
AdPharma is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Onconome is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.